Lichen International Limited
LICN
$3.12
-$0.13-4.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.13M | 7.13M | 11.69M | 11.69M | 9.05M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.13M | 7.13M | 11.69M | 11.69M | 9.05M |
| Cost of Revenue | 3.83M | 3.83M | 4.34M | 4.34M | 3.57M |
| Gross Profit | 3.30M | 3.30M | 7.35M | 7.35M | 5.48M |
| SG&A Expenses | 5.92M | 5.92M | 10.48M | 10.48M | 4.63M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.75M | 9.75M | 14.82M | 14.82M | 8.20M |
| Operating Income | -2.62M | -2.62M | -3.13M | -3.13M | 851.00K |
| Income Before Tax | -4.55M | -4.55M | -2.97M | -2.97M | 883.50K |
| Income Tax Expenses | 44.00K | 44.00K | 474.00K | 474.00K | 500.00K |
| Earnings from Continuing Operations | -4.59M | -4.59M | -3.44M | -3.44M | 383.50K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -87.00K | -87.00K | -9.50K | -9.50K | -- |
| Net Income | -4.68M | -4.68M | -3.45M | -3.45M | 383.50K |
| EBIT | -2.62M | -2.62M | -3.13M | -3.13M | 851.00K |
| EBITDA | -1.65M | -1.65M | -2.92M | -2.92M | 1.71M |
| EPS Basic | -16.54 | -16.54 | -17.00 | -17.00 | 2.26 |
| Normalized Basic EPS | -10.36 | -10.36 | -9.18 | -9.18 | 3.25 |
| EPS Diluted | -16.54 | -16.54 | -17.00 | -17.00 | 2.26 |
| Normalized Diluted EPS | -10.36 | -10.36 | -9.18 | -9.18 | 3.25 |
| Average Basic Shares Outstanding | 282.80K | 282.80K | 203.10K | 203.10K | 170.00K |
| Average Diluted Shares Outstanding | 282.80K | 282.80K | 203.10K | 203.10K | 170.00K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |